ERCC1 and esophageal cancer: In an important study, Leichman et al. demonstrated an inverse relationship between intra-tumoral ERCC1 mRNA expression and progression-free and overall survival in patients with operable esophageal cancer receiving neoadjuvant oxaliplatin-fluorouracil and radiation therapy18.